AwesomeCapital
Search This Blog
Monday, October 29, 2018
Piper Jaffray Starts Proteostasis Therapeutics (PTI) at Overweight
Piper Jaffray analyst Edward Tenthoff initiates coverage on Proteostasis Therapeutics (NASDAQ: PTI) with a Overweight rating
https://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Starts+Proteostasis+Therapeutics+%28PTI%29+at+Overweight/14751088.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.